174 related articles for article (PubMed ID: 8735296)
1. Malignant ovarian germ cell tumors.
Chow SN; Yang JH; Lin YH; Chen YP; Lai JI; Chen RJ; Chen CD
Int J Gynaecol Obstet; 1996 May; 53(2):151-8. PubMed ID: 8735296
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant germ cell tumors of the ovary.
Chang FH; Lai CH; Chu KK; Chang TC; Hsueh S; Hung IJ
J Formos Med Assoc; 1994 May; 93(5):411-6. PubMed ID: 7920081
[TBL] [Abstract][Full Text] [Related]
3. Recent management of malignant ovarian germ cell tumors: a study of 34 cases.
Linasmita V; Srisupundit S; Wilailak S; Tangtrakul S; Israngura N; Bullangpoti S
J Obstet Gynaecol Res; 1999 Oct; 25(5):315-20. PubMed ID: 10533325
[TBL] [Abstract][Full Text] [Related]
4. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy in the management of ovarian germ cell malignancies.
Schwartz PE
Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
[TBL] [Abstract][Full Text] [Related]
6. Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University.
El-Lamie IK; Shehata NA; Abou-Loz SK; El-Lamie KI
Eur J Gynaecol Oncol; 2000; 21(6):605-9. PubMed ID: 11214621
[TBL] [Abstract][Full Text] [Related]
7. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
Tangir J; Zelterman D; Ma W; Schwartz PE
Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
[TBL] [Abstract][Full Text] [Related]
8. [Comprehensive staging surgery in treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):826-30. PubMed ID: 16412329
[TBL] [Abstract][Full Text] [Related]
9. Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients.
Mayordomo JI; Paz-Ares L; Rivera F; López-Brea M; López Martín E; Mendiola C; Díaz-Puente MT; Lianes P; García-Prats MD; Cortés-Funes H
Ann Oncol; 1994 Mar; 5(3):225-31. PubMed ID: 7514435
[TBL] [Abstract][Full Text] [Related]
10. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
Grischke EM; Wallwiener D; Bastert G
Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
13. Current management of malignant germ cell tumor of the ovary.
Aziz MF
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
Hong W; Zhang R; Liu L
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
[TBL] [Abstract][Full Text] [Related]
15. Surveillance policy for stage I ovarian germ cell tumors.
Dark GG; Bower M; Newlands ES; Paradinas F; Rustin GJ
J Clin Oncol; 1997 Feb; 15(2):620-4. PubMed ID: 9053485
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP
Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380
[TBL] [Abstract][Full Text] [Related]
17. Childhood malignant ovarian germ cell tumors: a monoinstitutional experience.
Terenziani M; Massimino M; Casanova M; Cefalo G; Ferrari A; Luksch R; Spreafico F; Polastri D; Fontanelli R; Piva L; Fossati-Bellani F
Gynecol Oncol; 2001 Jun; 81(3):436-40. PubMed ID: 11371135
[TBL] [Abstract][Full Text] [Related]
18. Malignant ovarian germ cell tumors: a review of thirty-six cases.
Micha JP; Kucera PR; Berman ML; Romansky S; Flamm M; Reynolds J; DiSaia PJ
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):842-6. PubMed ID: 2411136
[TBL] [Abstract][Full Text] [Related]
19. Germ cell tumors of the ovary: is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors?
Bafna UD; Umadevi K; Kumaran C; Nagarathna DS; Shashikala P; Tanseem R
Int J Gynecol Cancer; 2001; 11(4):300-4. PubMed ID: 11520369
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
Culine S; Lhomme C; Kattan J; Duvillard P; Michel G; Droz JP
Eur J Cancer; 1994; 30A(9):1239-44. PubMed ID: 7528029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
